118 related articles for article (PubMed ID: 9228458)
21. Role of thyroid-stimulating blocking antibody in patients who developed hypothyroidism within one year after 131I treatment for Graves' disease.
Yoshida K; Aizawa Y; Kaise N; Fukazawa H; Kiso Y; Sayama N; Hori H; Nakazato N; Tani J; Abe K
Clin Endocrinol (Oxf); 1998 Jan; 48(1):17-22. PubMed ID: 9509063
[TBL] [Abstract][Full Text] [Related]
22. Use of cells expressing the human thyrotropin (TSH) receptor for the measurement of thyroid stimulating and TSH-blocking antibodies.
Vitti P; Chiovato L; Fiore E; Mammoli C; Rocchi R; Pinchera A
Acta Med Austriaca; 1996; 23(1-2):52-6. PubMed ID: 8767515
[TBL] [Abstract][Full Text] [Related]
23. Silent thyroiditis with thyroid-stimulation-blocking antibodies (TSBAb).
Nakamura S; Sugimoto M; Kosaka J; Watanabe H; Shima H; Kawahira S
Jpn J Med; 1990; 29(6):623-7. PubMed ID: 1983199
[TBL] [Abstract][Full Text] [Related]
24. Fluctuating thyroid function depending on the balance between stimulating and blocking types of TSH receptor antibodies: a case report.
Kasagi K; Hidaka A; Endo K; Miyamoto S; Takeuchi R; Misaki T; Sakahara H; Konishi J
Thyroid; 1993; 3(4):315-8. PubMed ID: 7906975
[TBL] [Abstract][Full Text] [Related]
25. Evidence for thyrotropin (TSH)-blocking activity in goitrous Hashimoto's thyroiditis with assays measuring inhibition of TSH receptor binding and TSH-stimulated thyroid adenosine 3',5'-monophosphate responses/cell growth by immunoglobulins.
Takasu N; Yamada T; Katakura M; Yamauchi K; Shimizu Y; Ishizuki Y
J Clin Endocrinol Metab; 1987 Feb; 64(2):239-45. PubMed ID: 2878935
[TBL] [Abstract][Full Text] [Related]
26. Short-term hyperthyroidism followed by transient pituitary hypothyroidism in a very low birth weight infant born to a mother with uncontrolled Graves' disease.
Higuchi R; Kumagai T; Kobayashi M; Minami T; Koyama H; Ishii Y
Pediatrics; 2001 Apr; 107(4):E57. PubMed ID: 11335778
[TBL] [Abstract][Full Text] [Related]
27. Thyroid-stimulating antibody and TSH-binding inhibitor immunoglobulin in 277 Graves' patients and in 686 normal subjects.
Takasu N; Oshiro C; Akamine H; Komiya I; Nagata A; Sato Y; Yoshimura H; Ito K
J Endocrinol Invest; 1997 Sep; 20(8):452-61. PubMed ID: 9364248
[TBL] [Abstract][Full Text] [Related]
28. Low prevalence of thyrotropin receptor antibody in primary hypothyroidism in Japan.
Tamaki H; Amino N; Kimura M; Hidaka Y; Takeoka K; Miyai K
J Clin Endocrinol Metab; 1990 Nov; 71(5):1382-6. PubMed ID: 1977757
[TBL] [Abstract][Full Text] [Related]
29. Thyroid blocking antibodies in thyroiditis.
Karlsson FA; Dahlberg PA; Ritzén EM
Acta Med Scand; 1984; 215(5):461-6. PubMed ID: 6146247
[TBL] [Abstract][Full Text] [Related]
30. Transient hypothyroidism in infants born to mothers with chronic thyroiditis--a nationwide study of twenty-three cases. The Transient Hypothyroidism Study Group.
Matsuura N; Konishi J
Endocrinol Jpn; 1990 Jun; 37(3):369-79. PubMed ID: 2253587
[TBL] [Abstract][Full Text] [Related]
31. Changes in the properties of the thyrotropin receptor antibody in patients with Graves' disease after radioiodine treatment.
Cho BY; Shong YK; Chung JK; Lee MC; Lee HK; Koh CS; Min HK
Thyroidology; 1989 Dec; 1(3):109-14. PubMed ID: 2484872
[TBL] [Abstract][Full Text] [Related]
32. [Idiopathic myxedema and blocking type antibodies to TSH receptor].
Mitsuma T
Nihon Rinsho; 1999 Aug; 57(8):1759-63. PubMed ID: 10483246
[TBL] [Abstract][Full Text] [Related]
33. Transient congenital hypothyroidism due to thyroid-stimulating hormone receptor blocking antibodies: a case series.
Evans C; Gregory JW; Barton J; Bidder C; Gibbs J; Pryce R; Al-Muzaffar I; Ludgate M; Warner J; John R; Moat SJ
Ann Clin Biochem; 2011 Jul; 48(Pt 4):386-90. PubMed ID: 21606073
[TBL] [Abstract][Full Text] [Related]
34. Clinical course and thyroid stimulating hormone (TSH) receptor antibodies during surgical treatment of Graves' disease.
Mori Y; Matoba N; Miura S; Sakai N; Taira Y
World J Surg; 1992; 16(4):647-52; discussion 652-3. PubMed ID: 1357830
[TBL] [Abstract][Full Text] [Related]
35. Measurement of TSH receptor blocking immunoglobulins using 3H-adenine incorporation into FRTL-5 and JPO9 cells: use in a child with neonatal hypothyroidism.
Michelangeli VP; Poon CW; Arnus EE; Frauman AG; Connelly J; Colman PG
Clin Endocrinol (Oxf); 1995 Jan; 42(1):39-44. PubMed ID: 7889630
[TBL] [Abstract][Full Text] [Related]
36. Prevalence and clinical relevance of thyroid stimulating hormone receptor-blocking antibodies in autoimmune thyroid disease.
Diana T; Krause J; Olivo PD; König J; Kanitz M; Decallonne B; Kahaly GJ
Clin Exp Immunol; 2017 Sep; 189(3):304-309. PubMed ID: 28439882
[TBL] [Abstract][Full Text] [Related]
37. Transient congenital hypothyroidism due to maternal thyrotrophin binding inhibiting immunoglobulin.
Schwingshandl J; Donaghue K; Luttrell B; Cowell C; Ward P; Silink M
J Paediatr Child Health; 1993 Aug; 29(4):315-8. PubMed ID: 8104016
[TBL] [Abstract][Full Text] [Related]
38. Thyroid response, especially to thyrotropin-binding inhibitory immunoglobulins, in euthyroid relatives of patients with Graves' disease: a clinical follow-up.
Tamai H; Kasagi K; Morita T; Hidaka A; Kuma K; Konishi J; Kumagai LF; Nagataki S
J Clin Endocrinol Metab; 1990 Jul; 71(1):210-5. PubMed ID: 1973421
[TBL] [Abstract][Full Text] [Related]
39. Pregnancy induces the presence of a thyroid-stimulating antibody in a thyrotropin-binding inhibitory immunoglobulin positive, hypothyroid woman with transient thyrotoxicosis in offspring.
Chang TC; Lee JS
J Formos Med Assoc; 1990 Aug; 89(8):709-13. PubMed ID: 1981235
[TBL] [Abstract][Full Text] [Related]
40. Immunoglobulins of untreated Graves' patients with or without thyrotropin receptor antibody (determined by porcine thyrocytes) universally elicit potent thyroid hormone-releasing activity in cultured human thyroid follicles.
Sato K; Yamazaki K; Yamada E; Kanaji Y; Miura M; Obara T
Thyroid; 1999 Oct; 9(10):979-88. PubMed ID: 10560951
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
